Reiji Tanaka

Title: Reiji Tanaka: Innovator in Neurodegenerative Disease Treatment

Introduction

Reiji Tanaka is a notable inventor based in Tsu, Japan. He has made significant contributions to the field of medical treatments, particularly in the area of neurodegenerative diseases. With a total of 2 patents, his work focuses on innovative methods that aim to improve patient outcomes.

Latest Patents

Tanaka's latest patents include groundbreaking methods for treatment and prevention using 4-deoxy-L-erythro-5-hexoseulose uronic acid. This method involves administering a therapeutically effective amount of DEH to promote nerve growth factor (NGF) activity, which is crucial in treating and preventing various neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis. Another significant patent involves a DNA sequence and expression vector for alginate lyase, which is used to produce DEH by interacting with alginate containing a uronic acid moiety.

Career Highlights

Reiji Tanaka is affiliated with Mie University, where he continues to engage in research and development in his field. His work has garnered attention for its potential to address critical health issues related to neurodegeneration.

Collaborations

Tanaka collaborates with esteemed colleagues, including Hideo Miyake and Toshiyuki Shibata, to further advance his research and innovations.

Conclusion

Reiji Tanaka's contributions to the field of neurodegenerative disease treatment through his patents and research at Mie University highlight his role as a significant innovator. His work promises to impact the future of medical treatments positively.